These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16380605

  • 1. Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease.
    Camicioli R, Kryscio R.
    Neurology; 2005 Dec 27; 65(12):1855-6. PubMed ID: 16380605
    [No Abstract] [Full Text] [Related]

  • 2. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA, Oulhaj A, de Jager CA, Williams JH.
    Neurology; 2005 Dec 27; 65(12):1888-93. PubMed ID: 16380608
    [Abstract] [Full Text] [Related]

  • 3. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B, Di Luca M, Padovani A.
    Neurology; 2007 Feb 20; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract] [Full Text] [Related]

  • 4. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L.
    Neurosci Lett; 2006 Mar 20; 396(1):23-7. PubMed ID: 16406347
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia.
    Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL.
    Arch Gen Psychiatry; 2006 Jan 20; 63(1):63-72. PubMed ID: 16389198
    [Abstract] [Full Text] [Related]

  • 6. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Jan 20; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 7. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW, Dekomien G, Nilsen OB, Larsen JP, Aarsland D, Alves G.
    J Geriatr Psychiatry Neurol; 2009 Sep 20; 22(3):166-70. PubMed ID: 19321880
    [Abstract] [Full Text] [Related]

  • 8. Distribution of APOE genotypes in a memory clinic cohort.
    van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P.
    Dement Geriatr Cogn Disord; 2008 Sep 20; 25(5):433-8. PubMed ID: 18401171
    [Abstract] [Full Text] [Related]

  • 9. MS and cognition and APOE: the ongoing conundrum about biomarkers.
    Sadovnick AD, Jacobs DH.
    Neurology; 2008 Jan 15; 70(3):164-5. PubMed ID: 18195261
    [No Abstract] [Full Text] [Related]

  • 10. Associations among plasma lipoprotein subfractions as characterized by analytical capillary isotachophoresis, apolipoprotein E phenotype, Alzheimer disease, and mild cognitive impairment.
    Zhang B, Matsunaga A, Saku K, Nakano S, Yamada T.
    Arterioscler Thromb Vasc Biol; 2004 Aug 15; 24(8):e144-6. PubMed ID: 15297290
    [No Abstract] [Full Text] [Related]

  • 11. The benefits of apolipoprotein E epsilon4 screening to research.
    Gauthier S.
    CMAJ; 2004 Oct 12; 171(8):881. PubMed ID: 15477627
    [No Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL, Laherrán E, Gutiérrez F, Martín-Polo J, Iglesias F, Alcázar C, Peralta J, Rostami P.
    Acta Neurol Scand; 2008 Jan 12; 117(1):21-5. PubMed ID: 17883422
    [Abstract] [Full Text] [Related]

  • 13. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L, Piccini C, Baccini M, Bessi V, Biancucci F, Nacmias B, Bagnoli S, Sorbi S.
    Dement Geriatr Cogn Disord; 2007 Jan 12; 24(6):483-91. PubMed ID: 18025782
    [Abstract] [Full Text] [Related]

  • 14. Long term neuropsychological outcome after head injury: relation to APOE genotype.
    Millar K, Nicoll JA, Thornhill S, Murray GD, Teasdale GM.
    J Neurol Neurosurg Psychiatry; 2003 Aug 12; 74(8):1047-52. PubMed ID: 12876232
    [Abstract] [Full Text] [Related]

  • 15. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.
    O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, Schatzberg AF, Yesavage JA, Murphy GM.
    Neurology; 2005 Aug 23; 65(4):642-4. PubMed ID: 16116137
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.
    Pharmacogenet Genomics; 2008 Apr 23; 18(4):289-98. PubMed ID: 18334913
    [Abstract] [Full Text] [Related]

  • 17. Mental deterioration late after head injury--does it happen?
    Brooks N.
    J Neurol Neurosurg Psychiatry; 2003 Aug 23; 74(8):1014. PubMed ID: 12876225
    [No Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E4 genotype is not associated with short-term cognition deficits during alcohol withdrawal.
    Wilhelm J, von Ahsen N, Frieling H, Hillemacher T, Bayerlein K, Bönsch D, Ziegenbein M, Kornhuber J, Bleich S.
    Alcohol; 2005 Nov 23; 37(3):151-6. PubMed ID: 16713503
    [Abstract] [Full Text] [Related]

  • 19. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
    Lind J, Persson J, Ingvar M, Larsson A, Cruts M, Van Broeckhoven C, Adolfsson R, Bäckman L, Nilsson LG, Petersson KM, Nyberg L.
    Brain; 2006 May 23; 129(Pt 5):1240-8. PubMed ID: 16537568
    [Abstract] [Full Text] [Related]

  • 20. The effects of stress and APOE genotype on cognition in older adults.
    Peavy GM.
    Am J Psychiatry; 2008 Nov 23; 165(11):1376-8. PubMed ID: 18981067
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.